Exagen Inc. Share Price

Exagen Inc. Share Price

NASDAQ: XGN | Micro Cap
$8.39
+$0.61 (7.84%) Last updated on 29 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Exagen Inc. Stock Performance

Open
$7.83
Prev. Close
$7.78
Circuit Range
N/A
Day Range
$7.83 - $8.48
Year Range
$2.61 - $11.97
Volume
23,852
Average Traded
$8.28

Exagen Inc. Share Price Today

As of 29 October 2026, Exagen Inc.'s share price is $8.39. The stock opened at $7.83, compared to its previous close of $7.78. During today's trading session, Exagen Inc.'s share price traded between $7.83 and $8.48, with an average price of $8.16. Over the past 52 weeks, the stock has recorded a high of $11.97 and a low of $2.61. In terms of performance, Exagen Inc.'s share price has risen by 188.81% over the last six months and is down 28.08% on a year-on-year basis.

Exagen Inc. Share Price Chart

Line chart of the Exagen Inc. price trend over the selected period. The price rose overall, ranging from 7.77 to 8.50, ending at 8.39.
$7.83$8.48
L
Show Current Price
H

Exagen Inc. Stock Fundamentals & Key Indicators

Market Cap
$180.87M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.78
Revenue (TTM)
$66.58B
Return On Equity (TTM)
-154.90%
Profit Margin
-29.96%
Debt to Equity
2.09
Quarterly Earnings Growth YoY
54.87%

Exagen Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$17.24$16.63$17.31$19.94
Net Profit-$7.09-$4.67-$3.97-$3.20
Net Profit Margin-41.13%-28.08%-22.93%-16.05%
Income ChangeN/A34.13%14.99%19.40%

Exagen Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$45.56$52.55$55.64$66.58
Net Profit-$47.39-$23.69-$15.12-$19.95
Net Profit Margin-104.02%-45.08%-27.17%-29.96%
Income ChangeN/A50.01%36.18%-31.94%

About Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Exagen Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$8.10
$8.36
+3.10%
Sep 2026
$7.21
$8.11
+7.90%
Aug 2026
$4.61
$7.51
+65.35%
Jul 2026
$4.78
$4.54
-2.57%
Jun 2026
$5.10
$4.67
-6.23%
May 2026
$2.99
$4.97
+71.26%
Apr 2026
$3.07
$2.90
-3.17%
Mar 2026
$3.50
$3.00
-16.90%
Feb 2026
$3.62
$3.61
-1.37%
Jan 2026
$6.07
$3.66
-39.90%
Dec 2025
$7.70
$6.09
-23.01%
Nov 2025
$11.71
$7.91
-32.19%

XGN Share Price FAQs